retatrutide trial weight loss The numbers from Lilly's Phase 3 dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Triple hormone receptor agonist retatrutide

Saxenda may increase the chance of food getting into your lungs during surgery or other procedures

Current Phase 3 trials (expected to report results in 2027) are exploring doses ranging from 4mg to 12mg weekly, with some protocols testing up to 16mg

The only difference may be in the vial size or the specific concentration of the lyophilized powder, which affects how much water you add

Whether retatrutide is different is speculation

A comprehensive approach considers diet, exercise, psychological support, and personalized treatment plans

And so slowly that cycle of looking at food as bad and feeling like a failure because you're eating what you should be, they begin to get healed from that disorder and pattern